IC
CELG

IKOS CIF’s Celgene Corp CELG Stock Holding History

IKOS CIF’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$84K Buy
+800
New +$86.6K 0.5% 53
2016
Q2 		– Sell
-7,738
Closed -$756K – 255
2016
Q1 		$756K Buy
+7,738
New +$797K 1.84% 7
2015
Q2 		– Sell
-3,393
Closed -$401K – 325
2015
Q1 		$401K Buy
3,393
+1,376
+68% +$164K 0.92% 6
2014
Q4 		$227K Buy
+2,017
New +$213K 0.38% 134

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

IKOS CIF's CELG Position: Q3 2016 in Review

IKOS CIF opened a new position in Celgene Corp (CELG) in Q3 2016: 800 shares worth $84K. The stake represents 0.5% of the portfolio and ranks #53 among its holdings. This is a return to the name: IKOS CIF previously reported a position in CELG as recently as Q1 2016.

IKOS CIF first reported a position in CELG in Q4 2014 and has held it in 4 quarters since. The position peaked at $756K in Q1 2016. 1,277 funds tracked by Wall St. Rank hold CELG as of Q3 2016.

  • IKOS CIF held 800 shares of Celgene Corp worth $84K as of Q3 2016.
  • Celgene Corp was a new IKOS CIF position in Q3 2016.
  • Celgene Corp made up 0.5% of IKOS CIF's portfolio in Q3 2016, its #53 holding.
  • IKOS CIF first reported a position in Celgene Corp in Q4 2014 and has held it in 4 quarters since.
  • IKOS CIF's Celgene Corp position peaked at $756K in Q1 2016.
  • 1,277 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2016.

Based on IKOS CIF's 13F filing for Q3 2016, filed 10 Nov 2016.